Aurinia Pharmaceuticals Inc (AUPH) returns
Aurinia Pharmaceuticals returns over 10 years
$1,000 invested in Aurinia Pharmaceuticals ten years ago was worth $5,155 at the close on October 30, 2026, with dividends reinvested: an average return of 17.8% a year. The same $1,000 in the S&P 500 (SPY) became $4,166.
Total return by period
| Period | Total return | A year, on average | $1,000 became | S&P 500 (SPY) |
|---|---|---|---|---|
| 1 month | +2.8% | — | $1,028 | -0.9% |
| 3 months | +11.0% | — | $1,110 | +2.1% |
| Year to date | +4.4% | — | $1,044 | +11.7% |
| 1 year | +37.4% | — | $1,374 | +12.4% |
| 3 years | +126.5% | +31.3% | $2,265 | +88.5% |
| 5 years | -49.7% | -12.8% | $503.33 | +76.0% |
| 10 years | +415.5% | +17.8% | $5,155 | +316.6% |
Aurinia Pharmaceuticals return by calendar year
| Year | AUPH | S&P 500 (SPY) | Difference |
|---|---|---|---|
| 2026 to date | +4.4% | +11.7% | -7.3% |
| 2025 | +77.6% | +17.7% | +59.9% |
| 2024 | -0.1% | +24.9% | -25.0% |
| 2023 | +108.1% | +26.2% | +81.9% |
| 2022 | -81.1% | -18.2% | -62.9% |
| 2021 | +65.4% | +28.7% | +36.6% |
| 2020 | -31.7% | +18.4% | -50.1% |
| 2019 | +197.1% | +31.2% | +165.8% |
| 2018 | +50.6% | -4.6% | +55.1% |
| 2017 | +115.7% | +21.7% | +94.0% |
| 2016 | -15.0% | +12.0% | -27.0% |
Past returns do not predict future returns. Returns are computed from our daily closes, adjusted for splits and with dividends reinvested on their ex-dates; taxes and trading costs are left out.
See also: AUPH financials · AUPH valuation
No forecast, no recommendation. This page describes Aurinia Pharmaceuticals Inc from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.